CXCL12 and cholangitis: We did not find a difference in biliary epithelial expression of CXCL12 between control liver and short- or long-term PSC-IBD, but as a proportion of our control liver tissue was derived from patients operated on for distal cholangiocarcinoma with subsequent secondary cholangitis and fibrosis, this could have led to a higher expression in the controls.